Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

BACKGROUND: 18F-FDG PET-CT is commonly used to monitor treatment response in patients with metastatic colorectal cancer (mCRC). With improvement in systemic therapy, complete metabolic response (CMR) is increasingly encountered but its clinical significance is undefined. The study examined the long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Keith W. H., Lam, Ka-On, An, H., Cheung, Gavin T. C., Lau, Johnny K. S., Choy, Tim-Shing, Lee, Victor H. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069713/
https://www.ncbi.nlm.nih.gov/pubmed/30064385
http://dx.doi.org/10.1186/s12885-018-4687-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069713/
https://www.ncbi.nlm.nih.gov/pubmed/30064385
http://dx.doi.org/10.1186/s12885-018-4687-9

Ejemplares similares